restor3d Launches Aeros Modular Stem Ankle System
DURHAM, N.C., April 2, 2026 restor3d, Inc., a leader in 3D-printed orthopedic medical devices, announced the full commercial release...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
DURHAM, N.C., April 2, 2026 restor3d, Inc., a leader in 3D-printed orthopedic medical devices, announced the full commercial release...
Atlanta, United States – March 10, 2026 Femasys Inc. has announced the initiation of patient enrollment in the FINALE...
Caesarea, Israel – March 9, 2026 A newly updated 2026 Resource Guide from the American Society of Breast Surgeons...
HAYWARD, Calif., March 4, 2026 Pulse Biosciences announced that its nPulseâ„¢ Vybranceâ„¢ System, powered by proprietary Nanosecond Pulsed Field...
February 25, 2026 – The Woodlands, Texas, USA Autonomix Medical, Inc. has announced the release of a new CEO...
STAMFORD, CT, September 25, 2025 — Apiject Systems, Corp., a leading medical technology innovator, submitted its New Drug Application...
